Rare diseases
Investigational molecules
Locations
Study on Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma
FranceLong-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension
AustriaStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
AustriaStudy on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
AustriaStudy on the Safety of Tafasitamab and Lenalidomide for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
AustriaStudy on RYZ101 for Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors After Previous Treatment
BelgiumStudy on Berzosertib and Gemcitabine for Adults with Advanced or Metastatic Soft-Tissue Leiomyosarcomas
FranceSafety Study of Damoctocog Alfa Pegol for Children Aged 7 to 11 with Severe Hemophilia A
ItalyStudy on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma
CzechiaStudy Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
AustriaStudy of adagrasib in elderly patients (70 years or older) or patients with poor performance status who have KRAS G12C mutation-positive non-small cell lung cancer
BelgiumStudy of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
